Association	O
of	O
Hypercalcemia	B:C0020437
Before	O
Treatment	O
With	O
Hypocalcemia	O
After	O
Treatment	I:C0001758
in	O
Dogs	O
With	O
Primary	O
Hyperparathyroidism	I:C0221002
.	O

Association	O
of	O
Hypercalcemia	O
Before	O
Treatment	B:C0087111
With	O
Hypocalcemia	O
After	O
Treatment	I:C0001758
in	O
Dogs	O
With	O
Primary	O
Hyperparathyroidism	I:C0221002
.	O

Association	O
of	O
Hypercalcemia	O
Before	O
Treatment	O
With	O
Hypocalcemia	B:C0020598
After	O
Treatment	I:C0001758
in	O
Dogs	O
With	O
Primary	O
Hyperparathyroidism	I:C0221002
.	O

Association	O
of	O
Hypercalcemia	O
Before	O
Treatment	O
With	O
Hypocalcemia	O
After	B:C0001758
Treatment	I:C0001758
in	O
Dogs	O
With	O
Primary	O
Hyperparathyroidism	I:C0221002
.	O

Association	O
of	O
Hypercalcemia	O
Before	O
Treatment	O
With	O
Hypocalcemia	O
After	O
Treatment	I:C0001758
in	O
Dogs	B:C0012984
With	O
Primary	O
Hyperparathyroidism	I:C0221002
.	O

Association	O
of	O
Hypercalcemia	O
Before	O
Treatment	O
With	O
Hypocalcemia	O
After	O
Treatment	I:C0001758
in	O
Dogs	O
With	O
Primary	B:C0221002
Hyperparathyroidism	I:C0221002
.	O

Development	O
of	O
hypocalcemia	B:C0020598
after	O
treatment	I:C0001758
of	O
hyperparathyroidism	O
results	O
in	O
increased	O
costs	O
and	O
risk	O
of	O
poorer	O
outcomes	I:C3806166
.	O

Development	O
of	O
hypocalcemia	O
after	B:C0001758
treatment	I:C0001758
of	O
hyperparathyroidism	O
results	O
in	O
increased	O
costs	O
and	O
risk	O
of	O
poorer	O
outcomes	I:C3806166
.	O

Development	O
of	O
hypocalcemia	O
after	O
treatment	I:C0001758
of	O
hyperparathyroidism	B:C0221002
results	O
in	O
increased	O
costs	O
and	O
risk	O
of	O
poorer	O
outcomes	I:C3806166
.	O

Development	O
of	O
hypocalcemia	O
after	O
treatment	I:C0001758
of	O
hyperparathyroidism	O
results	O
in	O
increased	O
costs	O
and	O
risk	O
of	O
poorer	B:C3806166
outcomes	I:C3806166
.	O

Previous	O
studies	B:C2603343
have	O
shown	O
conflicting	O
data	O
about	O
predictors	O
of	O
hypocalcemia	O
after	O
these	O
procedures	O
.	O

Previous	O
studies	O
have	O
shown	O
conflicting	O
data	O
about	O
predictors	O
of	O
hypocalcemia	B:C0020598
after	O
these	O
procedures	O
.	O

The	O
objective	B:C0018017
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	B:C2603343
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	B:C0373561
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	B:C0373561
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	B:C0087111
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	B:C0020598
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	B:C3540840
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	B:C0728940
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	B:C0547070
ablation	I:C0547070
in	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	B:C0012984
with	O
primary	O
hyperparathyroidism	I:C0221002
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
ionized	O
calcium	I:C0373561
(	O
ionized	O
calcium	I:C0373561
)	O
concentrations	O
before	O
treatment	O
are	O
predictive	O
of	O
hypocalcemia	O
or	O
its	O
clinical	O
signs	I:C3540840
after	O
surgical	O
removal	I:C0728940
or	O
heat	O
ablation	I:C0547070
in	O
dogs	O
with	O
primary	B:C0221002
hyperparathyroidism	I:C0221002
.	O

Fifty	O
-	O
four	O
dogs	B:C0012984
with	O
primary	O
hyperparathyroidism	I:C0221002
(	O
29	O
female	O
,	O
25	O
male	O
;	O
49	O
retrospective	O
,	O
5	O
prospective	O
)	O
.	O

Fifty	O
-	O
four	O
dogs	O
with	O
primary	B:C0221002
hyperparathyroidism	I:C0221002
(	O
29	O
female	O
,	O
25	O
male	O
;	O
49	O
retrospective	O
,	O
5	O
prospective	O
)	O
.	O

Fifty	O
-	O
four	O
dogs	O
with	O
primary	O
hyperparathyroidism	I:C0221002
(	O
29	O
female	O
,	O
25	O
male	O
;	O
49	O
retrospective	O
,	O
5	O
prospective	B:C0184820
)	O
.	O

Dogs	B:C0012984
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	O
(	O
ionized	O
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	O
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	O
treatment	O
.	O

Dogs	O
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	B:C0020437
(	O
ionized	O
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	O
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	O
treatment	O
.	O

Dogs	O
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	O
(	O
ionized	B:C0373561
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	O
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	O
treatment	O
.	O

Dogs	O
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	O
(	O
ionized	O
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	B:C0221002
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	O
treatment	O
.	O

Dogs	O
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	O
(	O
ionized	O
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	O
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	B:C0006674
treatment	O
.	O

Dogs	O
were	O
enrolled	O
if	O
they	O
met	O
the	O
inclusion	O
criteria	O
:	O
persistent	O
hypercalcemia	O
(	O
ionized	O
calcium	I:C0373561
>	O
1.41	O
mmol	O
/	O
L	O
)	O
due	O
to	O
primary	O
hyperparathyroidism	I:C0221002
and	O
absence	O
of	O
preemptive	O
calcitriol	O
treatment	B:C0087111
.	O

All	O
dogs	B:C0012984
were	O
treated	O
with	O
parathyroidectomy	O
(	O
n	O
=	O
37	O
)	O
or	O
percutaneous	O
ultrasound	O
-	I:C2315106
guided	I:C2315106
heat	I:C2315106
ablation	I:C2315106
(	O
n	O
=	O
17	O
)	O
.	O

All	O
dogs	O
were	O
treated	O
with	O
parathyroidectomy	B:C0079989
(	O
n	O
=	O
37	O
)	O
or	O
percutaneous	O
ultrasound	O
-	I:C2315106
guided	I:C2315106
heat	I:C2315106
ablation	I:C2315106
(	O
n	O
=	O
17	O
)	O
.	O

All	O
dogs	O
were	O
treated	O
with	O
parathyroidectomy	O
(	O
n	O
=	O
37	O
)	O
or	O
percutaneous	B:C0522523
ultrasound	O
-	I:C2315106
guided	I:C2315106
heat	I:C2315106
ablation	I:C2315106
(	O
n	O
=	O
17	O
)	O
.	O

All	O
dogs	O
were	O
treated	O
with	O
parathyroidectomy	O
(	O
n	O
=	O
37	O
)	O
or	O
percutaneous	O
ultrasound	B:C2315106
-	I:C2315106
guided	I:C2315106
heat	I:C2315106
ablation	I:C2315106
(	O
n	O
=	O
17	O
)	O
.	O

After	B:C0001758
treatment	I:C0001758
,	O
ionized	O
calcium	I:C0373561
was	O
monitored	O
twice	O
daily	O
until	O
plateau	O
or	O
intervention	O
.	O

After	O
treatment	I:C0001758
,	O
ionized	B:C0373561
calcium	I:C0373561
was	O
monitored	O
twice	O
daily	O
until	O
plateau	O
or	O
intervention	O
.	O

After	O
treatment	I:C0001758
,	O
ionized	O
calcium	I:C0373561
was	O
monitored	B:C1283169
twice	O
daily	O
until	O
plateau	O
or	O
intervention	O
.	O

After	O
treatment	I:C0001758
,	O
ionized	O
calcium	I:C0373561
was	O
monitored	O
twice	O
daily	O
until	O
plateau	O
or	O
intervention	B:C0184661
.	O

There	O
was	O
a	O
moderate	O
correlation	O
between	O
before	O
-	O
treatment	B:C0087111
hypercalcemia	O
and	O
after	O
-	I:C0001758
treatment	I:C0001758
hypocalcemia	O
.	O

There	O
was	O
a	O
moderate	O
correlation	O
between	O
before	O
-	O
treatment	O
hypercalcemia	B:C0020437
and	O
after	O
-	I:C0001758
treatment	I:C0001758
hypocalcemia	O
.	O

There	O
was	O
a	O
moderate	O
correlation	O
between	O
before	O
-	O
treatment	O
hypercalcemia	O
and	O
after	B:C0001758
-	I:C0001758
treatment	I:C0001758
hypocalcemia	O
.	O

There	O
was	O
a	O
moderate	O
correlation	O
between	O
before	O
-	O
treatment	O
hypercalcemia	O
and	O
after	O
-	I:C0001758
treatment	I:C0001758
hypocalcemia	B:C0020598
.	O

The	O
prospective	B:C0033522
study	I:C0033522
was	O
terminated	O
due	O
to	O
ethical	O
concerns	O
given	O
findings	O
in	O
the	O
retrospective	O
section	O
.	O

The	O
prospective	O
study	I:C0033522
was	O
terminated	O
due	O
to	O
ethical	O
concerns	O
given	O
findings	B:C0243095
in	O
the	O
retrospective	O
section	O
.	O

All	O
dogs	B:C0012984
were	O
placed	O
into	O
groups	O
according	O
to	O
their	O
pretreatment	O
ionized	O
calcium	I:C0373561
:	O
1.46-1.61	O
mmol	O
/L	O
,	O
1.62-1.71	O
mmol	O
/	O
L	O
,	O
ionized	O
calcium	I:C0373561
1.72-1.81	O
mmol	O
/	O
L	O
,	O
or	O
>	O
1.81	O
mmol	O
/	O
L.	O

All	O
dogs	O
were	O
placed	O
into	O
groups	O
according	O
to	O
their	O
pretreatment	O
ionized	B:C0373561
calcium	I:C0373561
:	O
1.46-1.61	O
mmol	O
/L	O
,	O
1.62-1.71	O
mmol	O
/	O
L	O
,	O
ionized	O
calcium	I:C0373561
1.72-1.81	O
mmol	O
/	O
L	O
,	O
or	O
>	O
1.81	O
mmol	O
/	O
L.	O

All	O
dogs	O
were	O
placed	O
into	O
groups	O
according	O
to	O
their	O
pretreatment	O
ionized	O
calcium	I:C0373561
:	O
1.46-1.61	O
mmol	O
/L	O
,	O
1.62-1.71	O
mmol	O
/	O
L	O
,	O
ionized	B:C0373561
calcium	I:C0373561
1.72-1.81	O
mmol	O
/	O
L	O
,	O
or	O
>	O
1.81	O
mmol	O
/	O
L.	O

After	B:C0001758
treatment	I:C0001758
,	O
the	O
mean	O
lowest	O
ionized	O
calcium	I:C0373561
for	O
each	O
group	O
,	O
respectively	O
,	O
was	O
1.19	O
,	O
1.18	O
,	O
1.13	O
,	O
and	O
1.01	O
mmol	O
/	O
L.	O

After	O
treatment	I:C0001758
,	O
the	O
mean	O
lowest	O
ionized	B:C0373561
calcium	I:C0373561
for	O
each	O
group	O
,	O
respectively	O
,	O
was	O
1.19	O
,	O
1.18	O
,	O
1.13	O
,	O
and	O
1.01	O
mmol	O
/	O
L.	O

There	O
was	O
a	O
significant	O
association	O
between	O
higher	O
group	O
and	O
proportion	O
of	O
dogs	B:C0012984
with	O
ionized	O
calcium	I:C0373561
<	O
1.00	O
mmol	O
/	O
L	O
(	O
P	O
=	O
.014	O
)	O
.	O

There	O
was	O
a	O
significant	O
association	O
between	O
higher	O
group	O
and	O
proportion	O
of	O
dogs	O
with	O
ionized	B:C0373561
calcium	I:C0373561
<	O
1.00	O
mmol	O
/	O
L	O
(	O
P	O
=	O
.014	O
)	O
.	O

This	O
study	B:C2603343
demonstrates	O
a	O
moderate	O
correlation	O
between	O
ionized	O
calcium	I:C0373561
concentration	O
before	O
treatment	O
and	O
hypocalcemia	O
after	O
treatment	I:C0001758
.	O

This	O
study	O
demonstrates	O
a	O
moderate	O
correlation	O
between	O
ionized	B:C0373561
calcium	I:C0373561
concentration	O
before	O
treatment	O
and	O
hypocalcemia	O
after	O
treatment	I:C0001758
.	O

This	O
study	O
demonstrates	O
a	O
moderate	O
correlation	O
between	O
ionized	O
calcium	I:C0373561
concentration	O
before	O
treatment	B:C0087111
and	O
hypocalcemia	O
after	O
treatment	I:C0001758
.	O

This	O
study	O
demonstrates	O
a	O
moderate	O
correlation	O
between	O
ionized	O
calcium	I:C0373561
concentration	O
before	O
treatment	O
and	O
hypocalcemia	B:C0020598
after	O
treatment	I:C0001758
.	O

This	O
study	O
demonstrates	O
a	O
moderate	O
correlation	O
between	O
ionized	O
calcium	I:C0373561
concentration	O
before	O
treatment	O
and	O
hypocalcemia	O
after	B:C0001758
treatment	I:C0001758
.	O

Dogs	B:C0012984
with	O
higher	O
initial	O
ionized	O
calcium	I:C0373561
concentrations	O
should	O
be	O
treated	O
to	O
prevent	O
rapid	O
decline	I:C2750110
and	O
development	O
of	O
clinical	O
hypocalcemia	O
.	O

Dogs	O
with	O
higher	O
initial	O
ionized	B:C0373561
calcium	I:C0373561
concentrations	O
should	O
be	O
treated	O
to	O
prevent	O
rapid	O
decline	I:C2750110
and	O
development	O
of	O
clinical	O
hypocalcemia	O
.	O

Dogs	O
with	O
higher	O
initial	O
ionized	O
calcium	I:C0373561
concentrations	O
should	O
be	O
treated	O
to	O
prevent	O
rapid	B:C2750110
decline	I:C2750110
and	O
development	O
of	O
clinical	O
hypocalcemia	O
.	O

Dogs	O
with	O
higher	O
initial	O
ionized	O
calcium	I:C0373561
concentrations	O
should	O
be	O
treated	O
to	O
prevent	O
rapid	O
decline	I:C2750110
and	O
development	O
of	O
clinical	O
hypocalcemia	B:C0020598
.	O

